Replies to post #144130 on Anavex Life Sciences Corp (AVXL)

[Fire Misleading]

False competition is stated in forward looking statements

This Quarterly Report on Form 10-Q includes forward-looking statements. All statements other than statements of historical facts contained in this Quarterly Report on Form 10-Q, including statements regarding our anticipated future clinical and regulatory milestone events, future financial position, business strategy and plans and objectives of management for future operations, are forward-looking statements. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “expect” “should,” “forecast,” “could,” “suggest,” “plan” and similar expressions, as they relate to us, are intended to identify forward-looking statements. Such forward-looking statements include, without limitation, statements regarding:
? our ability to generate any revenue or to continue as a going concern;
? our ability to successfully conduct clinical and preclinical trials for our product candidates;
? our ability to raise additional capital on favorable terms;
? our ability to execute our development plan on time and on budget;
? our products ability to demonstrate efficacy or an acceptable safety profile;
? our ability to obtain the support of qualified scientific collaborators;
? our ability, whether alone or with commercial partners, to successfully commercialize any of our product candidates that may be approved for sale;
? our ability to identify and obtain additional product candidates;
? intellectual property rights and protections;
? competition

[BIOChecker4]

No competitors with the same or similar MOA because nobody sees any value in AVXL's approach. Neither do serious investors.